Target intelligence / Profile preview

RORB antisense RNA 1 (RORB-AS1)

Target
RORB-AS1
Molecular classification
Other (long non-coding RNA, lncRNA)
01

Overview

RORB antisense RNA 1 (RORB-AS1) is a long non-coding RNA transcribed antisense to the RORB gene, located on human chromosome 9[5][6][7]. It does not encode a protein but functions primarily in the regulation of gene expression through RNA-mediated mechanisms[2]. RORB-AS1 is implicated in various biological and pathological processes, including the promotion of cancer cell growth and migration—especially in bladder cancer—by acting as a molecular sponge for tumor-suppressive microRNAs such as miR-504[2]. It may also be involved in epigenetic regulation via interaction with the polycomb repressive complex 2. Genome-wide association studies have linked RORB-AS1 to susceptibility for viral encephalitis and Alzheimer’s disease, as well as associations with certain forms of epilepsy[1][9]. There are no approved drugs known to directly target RORB-AS1, and it is not a conventional drug target like a receptor or enzyme, but it is being explored as a biomarker and a candidate for novel lncRNA-based therapeutic strategies[2].

Other names
RORB-AS1RORB antisense RNA 1
02

Mechanism of action

Regulation as a competing endogenous RNA (ceRNA) for miR-504 (acts as a molecular sponge); Epigenetic regulation by association with polycomb repressive complex 2

03

Biological functions

Regulation of gene expressionMolecular sponge for microRNAsRegulation of cell proliferationRegulation of cell migration
04

Disease associations

Cancer (bladder cancer, mantle cell lymphoma, colorectal cancer)Neurodegenerative disease (Alzheimer's disease risk association)Epilepsy (childhood, idiopathic generalized)
05

Safety considerations

Lack of therapeutic selectivity and off-target effects typical for lncRNA-targeted strategies (inferred)Not a druggable receptor, enzyme, or classical therapeutic target
06

Biomarkers

Prognostic biomarker in bladder cancerDisease susceptibility in viral encephalitis and Alzheimer’s disease

Beyond the preview

Go deeper on RORB antisense RNA 1 (RORB-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RORB antisense RNA 1 (RORB-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call